Labshake search
Citations for R&D Systems :
151 - 200 of 3217 citations for 1 3 Fluorophenyl 5 oxopyrrolidine 3 carboxylic acid since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2024Quote: ... The following primary antibodies were used: goat anti-Human/Mouse Caspase-3 (R&D Systems, Cat# AF-605-SP, 1:100-1:200), guinea pig anti-CNP1 (Synaptic Systems ...
-
bioRxiv - Microbiology 2020Quote: ... Primary BMDCs were isolated from C57BL/6 mice and cultured in Dulbecco’s modified Eagle medium for 3–5 days in the presence of 20 ng/mL recombinant granulocyte-macrophage colony-stimulating factor (R&D Systems, Minneapolis, MN, USA) as described previously (83) ...
-
bioRxiv - Microbiology 2021Quote: ... Primary antibodies for cleaved caspase-3 (catalog no. MAB835; R&D Systems) and polyclonal rabbit anti-N505 [55] were used at a concentration of 1:800 and 1:1000 respectively ...
-
bioRxiv - Immunology 2022Quote: ... Primary antibody against CD58 (CD58/LFA-3 goat polyclonal R&D system,) was used with a concentration of 1:100 (2 μg/ml ...
-
bioRxiv - Cell Biology 2021Quote: ... 10 ng/ml human IL-3 (203-IL-010, R&D Systems), 2 units/ml human-erythropoietin (100-64 ...
-
bioRxiv - Microbiology 2021Quote: ... and 3 dpi were measured using a DuoSet ELISA (R&D Systems). ELISA plates (Immunolon 2 ...
-
bioRxiv - Biochemistry 2022Quote: ... and 20 ng/mL fibroblast growth factor-3 (FGF3, R&D Systems) for the first 2 days and with 20 ng/mL FGF1 ...
-
bioRxiv - Immunology 2020Quote: ... 0.5 or 3 µg/mL (R&D Systems, Minneapolis, Minnesota, United States) in PBS buffer with 1.5% BSA and 0.025% Tween-20 ...
-
bioRxiv - Microbiology 2023Quote: ... Bacteria were treated with either 3 mM recombinant HMGB1 (R&D systems) or buffer in a 50 mL reaction at 37°C for 2 hours ...
-
bioRxiv - Bioengineering 2024Quote: ... 3 µm CHIR99021 (Stemgent) and 100 ng/ml SHH (R&D Systems) for 5 days ...
-
bioRxiv - Cancer Biology 2022Quote: ... and the Human TGF-beta 3 DuoSet ELISA Kit (R&D Systems).
-
bioRxiv - Neuroscience 2022Quote: ... and human NT-3 (10 ng/ml, 267-N3, R&D Systems) for another 20 days.
-
bioRxiv - Developmental Biology 2024Quote: ... or NT-3 10-20ng/ml (R&D Systems, #267-N3-005) on top of FGF8b 100ng/ml from day 9 to 16 ...
-
bioRxiv - Neuroscience 2024Quote: ... and rabbit anti-active caspase 3 (R&D systems, Minneapolis, MN, USA). The secondary antibodies used include donkey anti-rabbit 647 ...
-
bioRxiv - Microbiology 2024Quote: ... 3) 50 nM recombinant PolyHistidine-CYLD (R&D systems, Cat# E-556), or 50nM recombinant SdeC DUB (1-192 ...
-
bioRxiv - Neuroscience 2024Quote: ... + 3 ng/mL IL-1α (R&D systems; 400-ML-025/CF) + 30 ng/mL IFNγ (R&D systems ...
-
bioRxiv - Developmental Biology 2024Quote: ... 3 μM CHIR99021 and 20 ng/ml Activin (R&D Systems, 338AC010). Half of the medium was changed to DMEM with 10% FBS every other day ...
-
bioRxiv - Microbiology 2021Quote: ... IFN-<ι>λ1/3 concentrations were determined using commercial enzyme-linked immunosorbent assay (ELISA) kits (R&D Systems) following the manufacturer’s protocol ...
-
bioRxiv - Microbiology 2021Quote: ... 1 U/ml penicillin/streptomycin) with 3 ng/ml recombinant mouse GM-CSF (rGM-CSF; R&D Systems or BioLegend)) at a concentration of 2.5 x 105 cells/ml in 150 x 15 mm petri plates at 37°C with 5% CO2 ...
-
bioRxiv - Microbiology 2024Quote: ... 1 U/ml penicillin/streptomycin) with 3 ng/ml recombinant mouse GM-CSF (rGM-CSF; R&D Systems or BioLegend) at a concentration of 2.5 x 105 cells/ml in 150 x 15 mm petri plates at 37°C with 5% CO2 ...
-
bioRxiv - Cancer Biology 2023Quote: ... 0.3% Triton X-100) for 1 hour at room temperature and incubated with primary antibody against VE-cadherin (AF938, R&D Systems, 1:100) overnight at 4°C ...
-
bioRxiv - Biophysics 2023Quote: Collagen fibrils were formed by combining rat tail tendon-derived acid-soluble type I collagen (5 mg/mL in 20 mM acetic acid) (CultrexRat Collagen I, R&D Systems) with 400 mM HEPES + 0.02% sodium azide and 1 M NaCl at room temperature to reach final concentrations of 1 mg/mL collagen ...
-
bioRxiv - Cancer Biology 2024Quote: Xenograft studies were performed by subcutaneous bilateral implantation of 5E6 tumor cells/injection suspended 100 µl of 1: 1 RPMI / BME type 3 (R&D Systems #36-320-1002P). 4 to 6-week-old NOD-scid IL2Rgnull (NSG ...
-
bioRxiv - Cancer Biology 2024Quote: ... Approximately 2 x 106 cells were injected in 100 µL of a 1:1 (v/v) mixture of Cultrex basement membrane extract (BME) type 3 (Biotechne R&D Systems, Minneapolis, MN, USA) and sterile 1X phosphate buffered saline (PBS) ...
-
bioRxiv - Molecular Biology 2020Quote: ... Lambda interferon was evaluated by Human IL-29/IL-28B (IFN-lambda 1/3) DuoSet ELISA (DY1598B, R&D Systems, USA). Interleukin-6 was measured by Human IL-6 DuoSet ELISA (DY206 ...
-
bioRxiv - Immunology 2020Quote: ... genomic DNA was extracted from CH12 cells cultured for 3 days with TGF-β (1 ng/ml; R&D Systems Europe), IL-4 (5 ng/ml ...
-
bioRxiv - Synthetic Biology 2020Quote: ... 10 ng/mL transforming growth factor beta 3 (TGF-β3, R&D Systems) and 100nM dexamethasone12,27 to make implantable cartilage constructs11 ...
-
bioRxiv - Immunology 2023Quote: IFN-λ2/3 concentration was determined by commercial sandwich ELISA (R&D Systems) from supernatants infected or not with T ...
-
bioRxiv - Developmental Biology 2023Quote: ... Cells were cultured for 4 days with 3 μM CHIR (R&D Systems); 3 days with 200 ng/mL FGF9 (R&D Systems) ...
-
bioRxiv - Cancer Biology 2022Quote: ... 3-day old organoids were harvested with Cultrex Harvesting Solution (R&D Systems) and frozen in Recovery Cell Culture Freezing Medium (GIBCO) ...
-
bioRxiv - Cancer Biology 2023Quote: ... Recombinant human galectin 3 binding protein (R&D Systems, and produced in-house), QuikChange Lightning Site-Directed Mutagenesis Kit (Agilent Technologies) ...
-
bioRxiv - Cancer Biology 2023Quote: ... 3-day old organoids were harvested with Cultrex Harvesting Solution (R&D Systems) and frozen in Recovery Cell Culture Freezing Medium (GIBCO) ...
-
bioRxiv - Immunology 2024Quote: ... from 2-3 donors towards CXCL2 (R&D Systems, cat. 276-GB-010) and RARRES2 (R&D Systems ...
-
bioRxiv - Cancer Biology 2024Quote: ... Purified reagents using in this study included purified fibulin-3 (R&D Systems), highly-purified human IgG1 and human IgG Fc fragment (Rockland Immunochemicals) ...
-
bioRxiv - Immunology 2021Quote: ... After washing wells were incubated with a 5-bromo-4-chloro-3⍰-indolyl phosphate (BCIP)/nitro blue tetrazolium (NBT) substrate (R&D systems, mouse IFNγ Kit Cat # EL485). Plates were scanned and analyzed using ImmunoSpot Microanalyzer.
-
bioRxiv - Bioengineering 2020Quote: Lambda interferon levels were evaluated by human IL-29/IL-28B (IFN-lambda 1/3) DuoSet ELISA (DY1598B, R&D Systems, USA). Biological activity experiments were performed using ...
-
bioRxiv - Immunology 2020Quote: ... Cells were treated at 37 °C for 30 minutes with 15 μm Forskolin and 1:3 serial dilutions of potential ligands with the following starting concentrations: 10 μM recombinant human CXCL17 (R&D Systems), 10 μM lysophosphatidic acid (LPA ...
-
Kinetics Of Interferon-λ And Receptor Expression In Response To In Vitro Respiratory Viral InfectionbioRxiv - Immunology 2021Quote: ... Lambda IFN levels were evaluated by human IL-29/IL-28B (IFN-lambda 1/3) DuoSet ELISA (DY1598B, R&D Systems, USA). IL-6 was measured by human IL-6 DuoSet ELISA (DY206 ...
-
bioRxiv - Microbiology 2023Quote: ... Human IL-29/IL-28B (IFN-lambda 1/3) DuoSet ELISA or Human CXCL10/IP-10 DuoSet ELISA reagents (biotechne R&D systems) according to the manufacturer’s instructions.
-
bioRxiv - Cancer Biology 2022Quote: ... cocultures were treated with 3 μg/ml IL1α-neutralizing antibody (#MAB4001, R&D Systems) or isotype control antibody (#400902 ...
-
bioRxiv - Molecular Biology 2022Quote: ... Recombinant human WNT3A and R-spondin 3 were from R&D Systems (Minneapolis, USA).
-
The transcription factor RUNX2 drives the generation of human NK cells and promotes tissue residencybioRxiv - Immunology 2022Quote: ... FMS-like tyrosine kinase-3 ligand (FLT3-L) (100 ng/mL, R&D systems) and thrombopoietin (TPO ...
-
bioRxiv - Genomics 2021Quote: ... Polyclonal Goat Anti- Human/Mouse Oct-3/4 Antibody (R&D System, AF1759,1:20).
-
bioRxiv - Microbiology 2023Quote: Calu-3 cells were treated with exogenous β-IFN (R&D Systems, Minneapolis MN), baricitinib (Selleck Chemicals ...
-
bioRxiv - Immunology 2024Quote: ... 2mM L-Glutamine and 20ng/mL of recombinant human IL-3 (R&D systems). Cas9 and gRNA components were assembled into RNP per the manufacturer’s instructions and transfected into pDC 16 hrs p.c ...
-
Low-dose cytokine immunotherapy of solid cancers enabled by phagocytic-competent protein co-crystalsbioRxiv - Cancer Biology 2023Quote: ... 3 and 6 days and subsequently tested by IL-2 ELISA (R&D Systems) according to the manufacturer’s protocol.
-
bioRxiv - Genomics 2024Quote: ... M anti-DENV NS1 (Type 2/3/4) (Cat# MAB94441-100, R&D Systems), M anti-NXT1 (Cat#67680-1-Ig ...
-
bioRxiv - Developmental Biology 2024Quote: ... 10 ng/ml IL-3 and 80 ng/ml M-CSF (R&D Systems). On day 13 ...
-
bioRxiv - Bioengineering 2020Quote: ... Levels of hIFN-λ1 were evaluated by human IL-29/IL-28B (IFN-lambda 1/3) DuoSet ELISA (DY1598B, R&D Systems, USA), according to manufacturer’s instructions ...
-
bioRxiv - Cell Biology 2021Quote: ... HTM cells were cultured in serum-free DMEM with 1% PSG and subjected to the different treatments for 3 d: TGFβ2 (2.5 ng/ml; R&D Systems, Minneapolis, MN, USA), the ERK inhibitor U0126 (10 μM ...